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 Background: Although it has been reported that hypoxic exposure can attenuate hypertension, heart disease, diabetes, and 
some other diseases, effects of hypoxia on osteoporosis are still unknown.
 Material/Methods: The current study investigated whether short-term hypoxic exposure (in comparison with normoxic conditions) 
affects bone metabolism in normal or ovariectomized (OVX) adult female rats in an vivo study. Micro-computed 
tomography bone volume/structural analyses, histological examination, and serum bone turnover biochemi-
cal assays were used. In addition, the expressions of some associated major regulatory molecules were mea-
sured in osteoblastic cultures.
 Results: While the 14-day hypoxic exposure did not change the bone-remodeling process in normal adult female rats, 
it decreased bone volume, osteoclast density, and serum bone formation marker (alkaline phosphatase) lev-
el, but increased osteoclast density and serum bone resorption marker (C-telopeptide of collagen) level in OVX 
rats. The bone marrow adipocyte number and serum fatty acid binding protein-4 level were increased in OVX-
hypoxic rats compared with OVX-normoxic rats. Consistently, in human MG-63 osteoblastic cultures, the hy-
poxic condition suppressed protein expression of osteogenic transcriptional factors Runx2 and osterix, ele-
vated protein expression of osteoclastogenic cytokine receptor activator of nuclear factor kappa-B ligand, but 
reduced that of osteoclastogenic inhibitor osteoprotegerin.
 Conclusions: Our results suggest that, although no change occurred in the bone-remodeling process in normal adult female 
rats after hypoxic exposure, under the estrogen-deficient osteoporotic condition, the hypoxic condition can al-
ter the bone microenvironment so that it may further impair osteoblastic differentiation and enhance osteo-
clastic formation, and thus reduce bone formation, enhance bone resorption, and accelerate bone loss.
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Background
The hypoxic condition was considered as the primary compo-
nent of a high-altitude environment in past decades, which 
is known to lead physical and pathological changes in mam-
mals [1]. It has been widely reported that hypoxic exposure 
can attenuate hypertension, heart disease, diabetes, and re-
spiratory diseases, as well as central nervous system diseas-
es [2,3]. However, despite these potential beneficial effects of 
the hypoxic condition, no studies to date have investigated 
the effects of hypoxia on osteoporosis.
Osteoporosis is the most common metabolic skeletal disease 
worldwide and is characterized by a reduction in bone mass 
and bone strength, and an increase in fracture risk with great 
morbidity [4,5]. Although multiple mechanisms have been im-
plicated to be involved in osteoporosis, menopause and age-
related bone loss have been the major causes of primary os-
teoporosis [6,7]. Estrogen deficiency is considered to be the 
most important contributing factor in the pathological process 
of osteoporosis [8], and more than 90% of the osteoporosis-
related morbidity worldwide is observed in postmenopausal 
women more than 60 years old [9]. After menopause, bone re-
sorption (carried out by resorptive cell-osteoclasts) outpaces 
bone formation (carried out by bone-forming cell-osteoblasts) 
in the bone-remodeling process.
Recent in vitro studies reported that the hypoxic condition re-
duced osteoblastogenesis via inhibition of phosphatidylinositol 
3-kinase (PI3K)/Akt signal pathway [10,11]. However, no evidence 
has been presented so far indicating whether hypoxic exposure 
impairs the differentiation of osteoblasts and affects bone metab-
olism in vivo either with or without the postmenopausal state. The 
current study investigated whether hypoxic exposure (in compar-
ison to normoxic conditions) affects bone metabolism in normal 
adult rats or in ovariectomized (OVX) rats and expression of some 
associated major regulatory molecules in osteoblastic cultures.
Material and Methods
Animals and OVX/hypoxic models
Thirty-seven female Sprague Dawley (SD) rats (12 weeks old) 
were purchased from the Experimental Animal Center of Sun 
Yat-Sen University (Guangzhou, China) and were housed un-
der specific pathogen-free (SPF) conditions with day and night 
cycle of 12 h each. The temperature and humidity were main-
tained at 25±3°C and 65±5%, respectively. Thirteen rats were 
randomly separated into the hypoxic group (n=7) and the con-
trol normoxic group (n=6) without any operation. Following the 
separation, the hypoxic conditioning was initiated in the hypox-
ic group. Meanwhile, the other 24 female rats underwent an 
ovariectomy after being anesthetized via intraperitoneal injec-
tion of pentobarbital sodium-phosphate-buffered saline (PBS) 
solution with the dose of 30 mg/kg body weight at 12 weeks 
of age according to the classic protocol [12]. Four weeks after 
the operation, the OVX rats were randomly separated into hy-
poxic (n=12) or normoxic (n=12) groups. Exposure of rats to 
the hypoxic and normoxic conditions was performed accord-
ing to the classic protocol for experimental high-altitude imi-
tation [13]. No animal died in all the experimental processes.
After hypoxic or normoxic treatment for 14 days, rats were anes-
thetized via intraperitoneal injection of pentobarbital sodium-
PBS solution with the dose of 30 mg/kg body weight and were 
sacrificed for collecting blood samples and harvesting femur 
samples for various analyses described below. Blood samples 
were collected from the dorsal aorta and were centrifuged at 
4000 r/min for 6 min (4°C) to obtain serum. After centrifuga-
tion, serum samples were stored at –80°C.
Serum CTX, FABP-4, and ALP measurements
Serum bone turnover markers were analyzed by using rat en-
zyme-linked immunosorbent assay (ELISA) kits of C-telopeptide 
of collagen (CTX, a marker for bone resorption), alkaline phos-
phatase (ALP, a marker for bone formation), and fatty acid 
binding protein-4 (FABP-4, a marker for fatty acid metabolism 
and metabolic syndrome) (all purchased from BoHua Biotech, 
Shanghai, China) to examine treatment systemic effects on 
bone remodeling. Assays were carried out as instructed with 
absorbance being measured at 450 nm using an EL800 au-
tomated microplate reader (Bio-Tek Instruments, Winooski, 
Vermont, USA). The resulting concentrations of CTX (ng/mL), 
FABP-4 (ng/mL), and ALP (U/L) were measured using the re-
spective standard curves of the assays.
Micro-computed tomography
To examine treatment effects on bone structure and volume, 
proximal femoral metaphyses (a region known to be most ac-
tive in bone remodeling in rats) were analyzed by micro-com-
puted tomography (µ-CT), using the ZKKS-MCT-Sharp-III scan-
ner (Caskaisheng, Guangzhou, China). The femoral trabecular 
region was measured from 30 spongiosa slices (30 μm thick), 
and the growth plate was treated as the label to identify a con-
sistent location to start the region of interest for analysis. The 
3D-MED 3.0 software (Institute of Automation, Chinese Academy 
of Science, Xi’an, China) was used to measured the bone min-
eral density (BMD) and bone volume/tissue volume (BV/TV).
Histological analyses
For histological analyses, the right femurs were decalcified 
by glycerinum-EDTA (10% quality) for 12 weeks after fixation, 
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dehydrated with concentrated ethanol, and embedded in par-
affin wax after being washed with xylene; they then were cut 
into 5 μm sections. Femurs were cut sagittally at the distal fem-
oral region and cut transversally at the mid-diaphyseal level. 
For examining general bone morphology and measuring densi-
ties of osteoblasts and bone marrow adipocytes, sections were 
dewaxed and rehydrated, and then were subjected to routine 
hematoxylin and eosin (H&E) staining. According to the classic 
method [14], the trabecular bone surface-adhered cuboidal cells 
whose nuclei were co-stained with hematoxylin were counted 
as osteoblasts (cells/mm2 trabecular perimeter) in the second-
ary spongiosa. Meanwhile, the bone marrow adipose stacks 
whose nuclei were co-stained with hematoxylin were counted 
as adipose cells in the lower secondary spongiosa (cells/mm2 
bone marrow area). For identification of osteoclasts, one set 
of sections were stained for tartrate-resistant acid phospha-
tase (TRAP, a marker of osteoclasts) using the TRAP staining 
kit (Sigma-Aldrich, California, USA) and counter-stained with 
methyl green. In TRAP-stained sections, the irregular red cells 
whose nuclei were co-stained in green were counted in the 
secondary spongiosa as osteoclasts (cells/mm2 trabecular pe-
rimeter). Numbers of the above types of cells were counted 
by three volunteers in four fields randomly selected (400×) 
under blinding using ImagePro 4.5 software (Leeds Precision 
Instruments, Minneapolis, Minnesota, USA).
Hypoxic exposure of MG-63 osteoblastic cells and cell 
viability
To examine the effects of hypoxic exposure on osteoblasts 
in vitro, human osteosarcoma-derived osteoblastic MG-63 
cells were cultured in 75 cm2 flasks for 3 days in Dulbecco’s 
Modified Eagle Medium (DMEM, high glucose) supplemented 
with 10% fetal calf serum, penicillin 100 U/mL, and streptomy-
cin 100 mg/mL. Confluent cultures were trypsinized, passaged, 
and sub-cultured prior to being subjected to hypoxic/normox-
ic treatment. Hypoxic/normoxic conditions were applied after 
detached MG-63 cells were transplanted into six-well plates 
(2×105 cells/well) and cultured under normal conditions for 
12 hours. For the hypoxic condition, MG-63 cells were gassed 
with 95% N2 and 5% CO2 at 37°C for 1 h. Then cells were trans-
ferred into a normoxic incubator (95% air, 5% CO2) for an ad-
ditional 12 h for re-oxygenation.
To examine potential hypoxic treatment effects on cell viabili-
ty, a MTT assay was carried out. Following exposure to hypox-
ic or normoxic condition in vitro, 1×104 MG-63 cells were plat-
ed in a 96-well plate (150 µL of medium/well), then incubated 
at 37°C for 12 hours. Then, 20 µL of 5 mg/mL MTT solution in 
PBS was added to each well and mixed for 5 minutes prior to 
being incubated (37°C, 5% CO2), allowing MTT incorporation 
for 3 to 4 hours. Following incubation, the medium was dis-
carded and the wells were set to dry prior to formazan (MTT 
metabolic product) being thoroughly mixed and resuspended 
in 200 µL of DMSO. The optical density was measured at 560 
nm after subtracting the background measurement at 670 nm.
Western blot analyses
To examine the treatment effects in osteoblasts on protein expres-
sion of major regulatory genes of bone formation and resorption, 
MG-63 osteoblastic cells were washed with cold PBS, then lysed 
on ice for 30 min with radio immunoprecipitation assay (RIPA) 
buffer. Then, protein samples (30 mg respectively) were separat-
ed on 8% sodium dodecyl sulfate (SDS) gels and then transferred 
to polyvinylidene difluoride (PVDF) membranes. The membranes 
were incubated with rabbit-derived antibodies against receptor 
activator of nuclear factor kappa-B ligand (RANKL) and osteoprote-
gerin (OPG), Runt-related transcription factor 2 (RUNX-2), osterix, 
osteocalcin (1:1000; all from Santa Cruz Biotech, California, USA), 
and b-actin (1:1000; Bioworld Technology, St. Louis, Missouri, USA) 
after being blocked with dry skim milk-infused PBS buffer (4%) for 
1 h. Following these steps, the membranes were incubated with 
peroxidase-conjugated secondary antibody (goat anti-rabbit or 
a goat anti-mouse; 1:1000; Cell Signaling Technology, Shanghai, 
China) for 1 h and then were visualized by enhanced chemilumi-
nescence (ECL; Santa Cruz Biotech) using Kodak X-OMAT LS film 
(Eastman Kodak, Rochester, New York, USA) post PBS washing 
three times. All Western blot analyses in this study were repeat-
ed at least three times
Statistical analysis
Data were expressed as means ±SD, and one-way analysis of 
variance (ANOVA) was performed for the analysis of statisti-
cal significance. Representative experiments were presented 
in the result section and figures of this study. Statistical sig-
nificance was achieved when P<0.05.
Results
Effects of hypoxic exposure on trabecular bone volume 
and microarchitecture
Short-term hypoxic exposure did not appear to affect trabecu-
lar bone structure and volume in the normal rats. After 14 days 
of hypoxia exposure, as analyzed by µ-CT, no statistical dif-
ferences were observed in BMD, bone mineral content (BMC), 
BV/TV%, and trabecular number (Tb.N) between the hypoxic 
and normoxic groups (Figure 1A, 1B, 1E–1H).
However, hypoxic exposure for 14 days at 4 weeks after the 
ovariectomy procedure caused significant bone loss, although 
it did not affect the rate of body weight gain in OVX rats over 
3 months following the ovariectomy procedure. Following the 
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Figure 1.  Micro-CT analyses of effects of 14-day hypoxic or normoxic exposure on femoral distal trabecular bone mineral density 
(BMD), bone mineral content (BMC), bone volume/tissue volume (BV/TV%), and trabecular number (Tb.N) in normal (A, B, 
E–H) or ovariectomized (OVX) rats (C–H). A single asterisk (*) represents P<0.05; a double asterisk (**) represents P<0.01; a 
triple asterisk (***) represents P<0.001.
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hypoxic exposure in OVX rats, as examined by µ-CT scanning, 
there was a significant enhanced bone loss based on measure-
ments in BMD (P<0.05), BMC (P<0.05), BV/TV (P<0.05), and 
Tb.N (P<0.05) when compared with the normoxic OVX group 
(Figure 1C–1H). Meanwhile, compared with the normal hy-
poxic group, the significant reduction of BMD (P<0.001), BMC 
(P<0.001), BV/TV (P<0.001), and Tb.N (P<0.001) in the OVX 
group demonstrated the success of OVX-induced bone loss.
Treatment effects on osteoblast and osteoclast densities 
on trabecular bone surface as well as bone marrow 
adipocyte number
As shown in Figure 2, in normal rats, 14-day hypoxic treatment 
did not affect the osteoblast numbers (Figure 2A, 2B, 2I; P>0.05) 
and the osteoclast numbers (Figure 2E, 2F, 2J; P>0.05). However, 
in the OVX rats, the osteoblast number in the hypoxic group 
was statistically significantly lower than that in the normoxic 
group (Figure 2C, 2D, 2L; P<0.05), and the osteoclast number 
was significantly higher in the hypoxic OVX rats when com-
pared with the normoxic OVX rats (Figure 2G, 2H, 2J; P<0.01). 
On the other hand, compared with the normal-hypoxic group, 
the significant enhancement of osteoclast number and reduc-
tion of osteoblast number in the OVX group demonstrated the 
success of OVX-induced bone loss.
The numbers of adipose cells were counted on the H&E-stained 
sections at the femur bone marrow (at the lower secondary 
spongiosa region). While there were no significant differenc-
es in bone marrow adipocyte density in the normal rats be-
tween the hypoxic group and the normoxic group (Figure 2A, 
2B, 2K), there was a higher density of bone marrow adipo-
cytes in hypoxic OVX rats compared with normoxic OVX rats 
(Figure 2C, 2D, 2K; P<0.001). Therefore, the short-term hypox-
ic condition could influence the osteogenesis-related adipose 
metabolism in OVX rats, and this influence may be an estro-
gen-dependent process. As expected, the adipocyte densi-
ty in the OVX normoxic rats was higher than that in the nor-
mal normoxic rats.
Serum biochemical analyses of bone and adipose 
metabolism-related biomarkers
To examine treatment systemic effects on bone turnover and 
fat metabolism, serum levels of bone resorption marker CTX, 
bone formation marker ALP, and fatty acid metabolism and 
metabolic syndrome marker FABP-4 were analyzed. In the nor-
mal rats, no differences in serum levels of CTX, ALP, and FABP-
4 were observed between the hypoxic and normoxic groups 
(Figure 3A–3C). However, in OVX rats, hypoxic exposure signifi-




































































Figure 2.  Effects of 14-day hypoxic or normoxic exposure on densities of osteoblasts and adipocytes (normoxic: A, C; hypoxic: B, D; 
statistical analysis: I, K; on H&E-stained sections, 400× magnification) and osteoclasts (normoxic: E, G; hypoxic: F, H; 
statistical analysis: J; on TRAP-stained sections, 400× magnification) on femoral distal trabecular bone surfaces in normal or 
ovariectomized (OVX) rats. A single asterisk (*) represents P<0.05; a double asterisk (**) represents P<0.01; a triple asterisk 
(***) represents P<0.001.
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serum ALP level (Figure 3A–3C). Simultaneously, compared with 
the normal hypoxic group, the significant enhancements of 
CTX and FABP-4 levels and reduction of ALP level in the OVX 
group demonstrated the success of OVX-induced bone loss. 
These data indicated that a short-term hypoxic exposure did 
not alter the skeletal metabolism in normal rats but could ac-
celerate bone loss in OVX rats.
Effects of hypoxic exposure in osteoblastic cultures 
on expression of proteins regulating osteoblast and 
osteoclast formation
To investigate some potential mechanisms for hypoxia-in-
duced changes in bone/fat metabolism, treatment effects of 
hypoxia on cultured MG-63 osteoblastic cells were examined. 
A MTT cell viability test showed that there were no signifi-
cant differences in cell viability between the hypoxic and nor-
moxic groups of cells (Figure 4A). Through Western blotting 
analyses, treatment effects were examined on the expression 
levels of osteoblast differentiation markers (Runx2, OSX, and 
OCN) in MG-63 cells following hypoxic exposure (Figure 4B). 
While OCN expression in MG-63 cells was non-significantly 
different between the hypoxic condition and the normal con-
dition, the levels of Runx2 and OSX expression were lower in 
the cells exposed to the hypoxic condition compared with the 
normoxic condition (P<0.05 and 0.01, respectively). These data 
suggest that osteoblastic differentiation may be inhibited by 
hypoxic exposure. Furthermore, the expression of RANKL in 
MG-63 cells was significantly higher and the OPG level sig-
nificantly lower after hypoxia exposure when compared with 
normal culture (Figure 4C).
Discussion
Currently, potential effects of high-altitude living (e.g., high-
land residents) and hypoxia exposure on the morbidity of os-
teoporosis are not exactly understood. Recently, Bozzini et al. 
reported the effects of different simulated high altitudes (1850, 
2900, 4100, and 5450 m) on femur biomechanical properties 
in female growing rats that were exposed to the simulated 
high altitudes for more than 22 hours daily for 42 days [15]. 
It was found that, due to a smaller bone mass, the long bones 
of the hypoxia-exposed rats were weaker than those of nor-
moxia controls [15]. In the present study, we investigated the 
effects of short-term hypoxia, representative of a transient or 
non-sustained high-altitude environment, on bone metabolism 
in both normal and OVX rats and in vitro MG-63 osteoblas-
tic cells. This study showed that the short-term hypoxic expo-
sure did not change the bone-remodeling process in normal 
adult female rats; however, it decreased bone formation and 
increased bone resorption, and thus increased bone loss and 
enhanced bone marrow adipose tissue accumulation, in es-













































Figure 3.  Effects of 14-day hypoxic or normoxic exposure on serum levels of C-telopeptide of collagen (CTX), alkaline phosphatase 
(ALP), and fatty acid binding protein-4 (FABP-4) in normal or ovariectomized (OVX) (A–C) rats. A single asterisk (*) represents 
P<0.05; a double asterisk (**) represents P<0.01; a triple asterisk (***) represents P<0.001.
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culture impaired the osteoblastogenesis and enhanced expres-
sion of the osteoclastogenic signal (increased RANKL but OPG 
levels) of MG-63 osteoblasts in vitro. The post-hypoxic condi-
tion osteoclastogenic enhancement in our study is consistent 
with the past study of human osteoclasts that underwent hy-
poxia exposure [16]. Therefore, these data indicate that short-
term hypoxic exposure may accelerate bone loss in OVX rats 
or in postmenopausal women with osteoporosis.
In this study, bone loss was shown to be enhanced in OVX rats 
by short-term hypoxic exposure, which was accompanied by 
an increase in the number of bone-resorptive osteoclasts and 
a decrease in the number of bone-forming osteoblasts on tra-
becular bone surfaces. Although OVX models were performed 
for more than 8 weeks in most studies, the hypoxic exposure 
in our study was measured at 4 weeks post OVX to avoid se-
vere and irreversible bone loss of rats [17]. In addition, there 
was an increased serum level of the bone resorption marker 
CTX but a decreased serum level of the bone formation mark-
er ALP, as well as an increase in adipocyte density in the bone 
marrow, following hypoxic exposure in OVX rats. While these 
changes were not observed in normal rats after hypoxic ex-
posure, this suggests that imbalanced bone remodeling (de-
creased bone formation and increased bone resorption) caused 
by hypoxia occurs in female rats when estrogen is deficient. 
This can imply that short-term hypoxic exposure in postmeno-
pausal women may cause accelerated bone loss.
As multiple signal pathways are involved in the bone remod-
eling system, the factors contributing to the changes in bone 
metabolism as a result of hypoxia still need to be investigated 
[10]. The hypoxic microenvironment has been considered as a 
vital factor for the hypoxia-induced factor (HIF-1)-dependent 
angiogenesis that is critical for bone formation during bone de-
velopment and regeneration after trauma [18,19]. Consistently, 
bone marrow stromal cell differentiation and osteoblastogen-
esis can be inhibited by hypoxic culture in vitro [20]. However, 
potential molecular mechanisms for hypoxic exposure-induced 
bone loss in OVX rats remain to be clarified in future studies. 
In addition, although it has been reported in the past decades 
that hypoxia can increase adipogenesis, no clear evidence has 
indicated that the adipogenesis in bone marrow can be mod-
ulated by hypoxic exposure in vivo [21].
As a means to investigate potential mechanisms of the impact 
of hypoxia on bone remodeling, the current study also exam-
ined hypoxic-exposure effects on osteoblast viability and ex-
pression of genes regulating osteoblastogenesis and osteoclas-
togenesis in treated MG-63 osteoblastic culture. While recent 
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Figure 4.  Effects of hypoxic or normoxic exposure on cell viability as examined by MTT assays (A) and protein expression of 
osteogenesis-related molecules (Runx2, OSX, and OCN) (B–E), as well as osteoclastogenesis-regulatory molecules (RANKL and 
OPG) (F–H) as analyzed by Western blot analyses (with the internal loading control b-actin) in cultured osteoblastic MG-63 
cells. Statistical analyses of Western blot test results. A single asterisk (*) represents P<0.05; a double asterisk (**) represents 
P<0.01; a triple asterisk (***) represents P<0.001.
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the cell cycle of osteoblasts and block their proliferation, the 
current study showed that the hypoxic exposure did not affect 
osteoblast viability as measured by MTT assays [11]; this con-
tradiction may be because the vitro hypoxia imitation in our 
study was a mild and short-term exposure (5% O2 for 1 hour). 
Although the terminal biomarker of osteogenesis, osteocalcin, 
showed low expression with both hypoxic exposure and nor-
mal culture in vitro due to the limited culture time, our study 
demonstrated that the hypoxic condition suppressed protein 
expression of osteogenic biomarkers including transcription-
al factors Runx2 and OSX [22], suggesting that hypoxic treat-
ment of osteoblastic culture can reduce osteoblast differenti-
ation. This finding is consistent with the recent study where 
osteoblastic differentiation was shown to be inhibited by the 
hypoxic condition [20].
In addition, as osteoclastogenesis is modulated by osteoblasts 
through the RANK/RANKL/OPG signal pathway [8], this study 
measured the expression of the key osteoclastogenic cytokine 
RANKL and the major osteoclastogenic inhibitor OPG in osteo-
blasts exposed to hypoxic conditions in vitro. We showed that 
the treated osteoblastic culture had elevated protein expres-
sion of RANKL but a reduced level of OPG, suggesting that 
hypoxia-treated osteoblasts have a higher ability to induce 
osteoclastic differentiation and formation and osteoclastic ac-
tivity. These results suggest that a high-altitude environment 
may impair osteoblastic differentiation and enhance osteo-
clastic formation. In addition, while it has been demonstrat-
ed that estrogen can induce the apoptosis of osteoclasts and 
estrogen deficiency could stimulate osteoclastogenesis in OVX 
rats [23,24], potential interaction of estrogen action and the 
RANK/RANKL/OPG system in osteoclastic over-formation un-
der the hypoxic condition remains to be investigated. Further 
studies are required to verify whether the hypoxia-induced 
accelerated bone loss in OVX rats may be due to the reduced 
differentiation of osteoblasts and over-formation and/or ac-
tivation of osteoclasts resulting from higher level RANKL but 
lower level OPG in osteoblasts.
On the other hand, the imbalance of BMSC differentiation is 
considered to be a major factor in menopausal osteoporosis; 
the increased fat mass in the bone marrow has been shown 
to be associated with a reduction in bone mass, and this bone 
loss and bone marrow adiposity inverse relationship has been 
demonstrated [25,26]. In our results, consistent with recent in-
vestigations, the fat mass was elevated in OVX rats; further-
more, the hypoxic exposure also enhanced the adipogenesis 
of bone marrow significantly in OVX rats. Although these re-
sults suggest that the hypoxic condition may have altered the 
balance of adipose/osteoblast differentiation of bone marrow 
MSCs and resulted in bone loss and adipogenesis, deeper elab-
oration of a mechanism is still needed. Simultaneously, con-
sistent with our results, a recent report suggested that bone 
marrow adipocytes influenced the coupling of osteoblast and 
osteoclast differentiation, and may be relevant to bone-loss 
disorders [27].
Conclusions
This study observed an enhanced bone loss in OVX rats (ac-
companied by reduced bone formation, increased resorption, 
and bone marrow adiposity) following hypoxic exposure. These 
findings suggest that high-altitude environments may play a 
harmful role in bone metabolism and contribute to the devel-
opment/progression of postmenopausal osteoporosis. Although 
our in vitro studies suggest that the hypoxic condition can sup-
press osteogenic differentiation and enhance osteoclastic for-
mation, further studies are required to investigate whether it 
is so under an estrogen-deficient culture condition, and future 
work is required to study potential mechanisms for the en-
hanced bone loss in rats with estrogen deficiency.
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